inVentiv Health Clinical has appointed of a president of Phase II-IV Development, chief medical Officer, and chief Financial Officer to strengthen its leadership team. Dawn Anderson joins inVentiv Clinical as president, Phase II-IV Development, Martin Birkhofer, M.D.  assumes the newly created position of chief medical officer, and Richard Shimota becomes chief financial officer. Ms. Anderson, Dr. Birkhofer, and Mr. Shimota will serve on the inVentiv’s executive leadership team. The addit...